Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)

ClinicalTrials.gov ID: NCT06226805

Public ClinicalTrials.gov record NCT06226805. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 20, 2026, 8:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-blinded, Placebo-controlled, Single Ascending Dose, Two-part, Randomized, Phase 2 Clinical Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BB-031 in Acute Ischemic Stroke Patients

Study identification

NCT ID: NCT06226805
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Basking Biosciences, Inc.; Industry
Enrollment: 228 participants

Conditions and interventions

Conditions

Acute Ischemic Stroke

Interventions

BB-031 Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 30, 2024
Primary completion: May 31, 2027
Completion: Aug 31, 2027
Last update posted: May 13, 2026

2024 – 2027

United States locations

U.S. sites: 15
U.S. states: 9
U.S. cities: 14

Facility	City	State	ZIP	Site status
HonorHealth Bob Bove Neuroscience Institute	Scottsdale	Arizona	85251	Recruiting
Mills Peninsula Medical Center	Burlingame	California	94010	Withdrawn
MemorialCare Long Beach Medical Center	Long Beach	California	90806	Withdrawn
California Pacific Medical Center	San Francisco	California	94109	Withdrawn
Pacific Neurosciences Institute at Saint John's Physician Partners	Torrance	California	90503	Recruiting
Baptist Health Medical Center	Jacksonville	Florida	32207	Terminated
Henry Ford Hospital	Detroit	Michigan	48202	Recruiting
Washington University in St. Louis	St Louis	Missouri	63110	Recruiting
Cooper University Hospital	Camden	New Jersey	08103	Recruiting
WakeMed	Raleigh	North Carolina	27610	Recruiting
The Ohio State University	Columbus	Ohio	43210	Recruiting
ProMedica Toledo Hospital	Toledo	Ohio	43604	Recruiting
Mercy Health St. Vincent Medical Center	Toledo	Ohio	43608	Recruiting
Valley Baptist Medical Center - Harlingen	Harlingen	Texas	78550	Recruiting
Memorial Hermann Hospital	Houston	Texas	77030	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06226805, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 13, 2026 · Synced May 20, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06226805 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →